ArticleBMC pregnancy and childbirth2026
Associations of trimethylamine N-oxide and its precursors with hypertensive disorders of pregnancy, its subtypes and blood pressure in the offspring: findings from the Shanghai Birth Cohort.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundTrimethylamine N-oxide (TMAO) and its precursors (choline, betaine, and carnitine) have been associated with hypertension in nonpregnant adults, yet limited research exists on their relationship with hypertensive disorders of pregnancy (HDP). Additionally, no prior studies have investigated whether TMAO and its precursors influence offspring blood pressure (BP).
objectivesThis study aims to examine the associations of TMAO and its precursors during early pregnancy with the risk of HDP and its subtypes (gestational hypertension (GH), preeclampsia (PE) and eclampsia) and BP in four-year-old children within the Shanghai Birth Cohort. STUDY
designPlasma TMAO and its precursors were measured at 10-12 gestational weeks via liquid chromatography-mass spectrometry. Logistic regression was employed to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) to evaluate their associations with HDP and its subtypes, while linear regressions examined their relationships with childhood systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP).
resultsThe study involved 1985 pregnant women and 803 four-year-old children. TMAO levels in the second quartile are linked to an increased risk of HDP (OR = 1.49, 95% CI: 1.03-2.16) and GH (OR = 1.57, 95% CI: 1.06-2.33) compared to the lowest quartile. The ORs for the highest quartile of betaine, compared with the lowest quartile, are 0.64 (95% CI: 0.44-0.93) for HDP risk and 0.61 (95% CI: 0.41-0.90) for GH risk, respectively. In the highest quartile of carnitine compared to the lowest quartile, carnitine level is negatively associated with the incidence of PE and eclampsia (OR = 0.32, 95% CI: 0.12-0.84), and positively associated with the incidence of GH (OR = 1.58, 95% CI: 1.06-2.36). Additionally, maternal carnitine positively correlated with child SBP (β = 0.13 mmHg, 95% CI: 0.01-0.24) and MAP (β = 0.10 mmHg, 95% CI: 0.01-0.19).
conclusionsElevated level of TMAO is associated with an increased risk of HDP, while higher betaine levels exhibit a protective effect. Carnitine is positively associated with the risk of GH. These findings suggest that TMAO and its precursors may serve as potential biomarkers for early HDP identification and prevention. However, future well-designed studies are needed to further investigate the associations of TMAO and its precursors with HDP, its subtypes, and offspring BP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.